Embio Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U24110MH1986PLC038680 Incorporated 20 January 1986 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹274.76 Cr
▲ 49.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹43.62 Cr
Registered with MCA
Paid-up capital
₹4.7 Cr
Issued & subscribed
Open charges
₹66.03 Cr
Satisfied ₹109.3 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
600
Latest available

About Embio Limited

Data last updated: 11 January 2026

Embio Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Malladi Industries Private Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 20 January 1986, the company has been in operation for over 40 years.

Registered with ROC Mumbai under CIN U24110MH1986PLC038680.

Capital: an authorised share capital of ₹43.62 Cr and a paid-up capital of ₹4.7 Cr. Formerly known as Emmellen Biotech Pharmaceuticals Ltd. It is led by directors including Madhusudan Rao Garimella and Ajit Tekchand Vaswani.

Last AGM: 22 September 2025. Financial statements filed for year ended 31 March 2025. Office: 501 Sentinel 5Th Floor Hiranandani Gardens Powai, Mumbai, Maharashtra, India – 400076.

As per the financials filed for FY 2025, the company reported a revenue of ₹274.76 Cr, a growth of 49% compared to the previous year.

The company has a workforce of approximately 600 employees as per the latest available data. It operates as a subsidiary of Malladi Industries Private Limited.

The company is associated with 1 brand - Embio. As per MCA filings, the company has open charges of ₹66.03 Cr and satisfied charges of ₹109.3 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website embio.co.in.

Company Details of Embio Limited
CIN U24110MH1986PLC038680
Registration Number 038680
Incorporation Date 20 January 1986
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 22 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Malladi Industries Private Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    501 Sentinel 5Th Floor Hiranandani Gardens Powai, Mumbai, Maharashtra, India – 400076
  • Industry
    Pharma, API Manufacturers
Company report
Embio Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Embio Limited report

Financials, compliance, directors, charges, ownership and filings for Embio Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Embio Limited

Embio Limited has one previous CIN (Corporate Identification Number): L24110MH1986PLC038680. The current CIN is U24110MH1986PLC038680, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24110MH1986PLC038680 Current
L24110MH1986PLC038680 Previous

Associated Brands with Embio Limited

Embio Limited operates one associated brand: Embio. These brands represent Embio Limited's diversified market presence and brand portfolio.

Brand Description Website
APIs and chiral intermediates are manufactured by Embio under contract. embio.co.in

Competitors & Alternatives of Embio Limited

Brands and companies operating in the same space as Embio Limited include Laurus Labs, Symbiotec, Sterling Pharma Solutions and 5 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Apicore Apicore APIs are manufactured and custom synthesis services are provided. Somerset, United States, United States 2004
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978
Bellen Chemistry Bellen Chemistry APIs and intermediates are researched and manufactured, specializing in heterocycles. Beijing, China, China 2007

Business Activity of Embio Limited

Embio Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Embio Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Embio Limited

Embio Limited is audited by SSPA & Associates for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
SSPA & Associates Locked Locked Locked
Premium access

Complete auditor history for Embio Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Embio Limited

Embio Limited is currently managed by 5 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Madhusudan Rao Garimella Director 07 Aug 2017 9 Years 0 Months Current
Ajit Tekchand Vaswani Director 16 Oct 2001 24 Years 9 Months Current
Devesh Malladi Managing Director 01 Oct 2007 18 Years 10 Months Current
Raghavachari Kasthuri Rangan Director 20 Sep 2024 1 Years 10 Months Current
Aadya Malladi Additional Director 26 Jun 2025 1 Years 1 Months Current

Financials of Embio Limited FY 2025 filings available

Embio Limited reported revenue of ₹274.76 Cr (up 49.00% YoY) for FY 2025.

Revenue · FY 2025
₹274.76 Cr ▲ 49.00%
Premium access

Ten-year financial statements for Embio Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Embio Limited

Premium access

Shareholding and ownership data for Embio Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Embio Limited

Open charges
₹66.03 Cr
Satisfied charges
₹109.3 Cr
Breakdown by lending institutions
Axis Bank Limited₹50.00 Cr
State Bank of India₹14.03 Cr
Biotechnology Industry Research Assistance Council₹2.00 Cr
Latest charge details
DateLenderAmountStatus
07 Mar 2022 Axis Bank Limited ₹25 Cr Open
10 Dec 2012 Biotechnology Industry Research Assistance Council ₹2 Cr Open
03 Dec 2002 Axis Bank Limited ₹25 Cr Open
28 Jun 1995 State Bank of India ₹14.03 Cr Open
28 May 2015 Hdfc Bank Limited ₹30 Lakh Satisfied

Total charge records: 33 View all charges

Employees and EPFO Compliance at Embio Limited

Embio Limited has a workforce of 600 employees as of Apr 05, 2024.

Employee count
600
Active EPFO establishments
1
Employee growth
0.33%
Premium access

Employee and EPFO history for Embio Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Embio Limited

Premium access

GST registrations and filing compliance for Embio Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Embio Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Embio Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Embio Limited

Premium access

MSME payment history for Embio Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Embio Limited

Premium access

Corporate group structure for Embio Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Embio Limited

Premium access

MCA filings and documents for Embio Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Embio Limited

Activity
22 Sep 2025
Embio Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records.
Directors
26 Jun 2025
Aadya Malladi was appointed as a Additional Director on 26 Jun 2025 & has been associated with this company since 1 year 1 month.
Activity
31 Mar 2025
Embio Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
20 Sep 2024
Raghavachari Kasthuri Rangan was appointed as a Director on 20 Sep 2024 & has been associated with this company since 1 year 10 months.
Charges
08 Sep 2022
A charge with Axis Bank Limited of Rs. 25.00 Cr registered on 07 Mar 2022 with Charge ID 100554671 was modified on 08 Sep 2022.
Charges
08 Sep 2022
A charge with Axis Bank Limited of Rs. 25.00 Cr registered on 03 Dec 2002 with Charge ID 80046613 was modified on 08 Sep 2022.

Frequently Asked Questions about Embio Limited

Embio Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 20 January 1986 (40+ years old) and is registered under CIN U24110MH1986PLC038680. The company has 600 employees.

Embio Limited reported revenue of ₹274.76 Cr for FY 2025 (up 49.00% YoY).

The current directors of Embio Limited are:

The primary industry of Embio Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Embio Limited can be reached at the registered office: 501 Sentinel 5Th Floor Hiranandani Gardens Powai, Mumbai, Maharashtra, India – 400076, or through the website embio.co.in.

The authorised capital is ₹43.62 Cr, and the paid-up capital is ₹4.7 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available